Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis-Reference-Cited by-同舟云学术

Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis

Published:2020-10 Issue:5 Volume:20 Page:e600-e611
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Marazzi Fabio,Barone Roberto,Masiello Valeria^ORCID,Magri Valentina^ORCID,Mulè Antonino,Santoro Angela,Cacciatori Federica^ORCID,Boldrini Luca,Franceschini Gianluca,Moschella Francesca,Naso Giuseppe,Tomao Silverio,Gambacorta Maria Antonietta,Mantini Giovanna,Masetti Riccardo,Smaniotto Daniela,Valentini Vincenzo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Progress in the clinical detection of heterogeneity in breast cancer;Song;Cancer Med,2016

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci U S A,2001

3. Molecular portraits of human breast tumours;Perou;Nature,2000

4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, 2015;Coates;Ann Oncol,2015

5. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence;ecancermedicalscience;2024-02-06

2. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing;Cancers;2023-01-31

3. Shear-wave elastography-based nomograms predicting 21-gene recurrence score for adjuvant chemotherapy decisions in patients with breast cancer;European Journal of Radiology;2023-01

4. Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age;Breast Cancer Research and Treatment;2022-10-21